Bortezomib is a new proteasome inhibitor.Clinical studies demonstrat that bortezomib plays role in the treatment for relapsed, refractory and initially treated multiple myeloma.

• 硼替佐米作为一种新型的蛋白酶体抑制剂,临床上可用于治疗复发性、难治性或初治的多发性骨髓瘤。